Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current HIV treatment guidelines--an overview.

R C Rathbun1, S M Lockhart, J R Stephens

  • 1College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. Chris-Rathbun@ouhsc.edu

Current Pharmaceutical Design
|March 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GDF15 linked to maternal risk of nausea and vomiting during pregnancy.

Nature·2023
Same author

Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy.

bioRxiv : the preprint server for biology·2023
Same author

Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis.

The British journal of surgery·2021
Same author

Insulin resistance in vascular endothelial cells promotes intestinal tumour formation.

Oncogene·2017
Same author

HIV Pharmacist's Impact on Inpatient Antiretroviral Errors.

HIV medicine·2016
Same author

The effect of direction of force to the craniofacial skeleton on the severity of brain injury in patients with a fronto-basal fracture.

International journal of oral and maxillofacial surgery·2016
Same journal

Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

Current pharmaceutical design·2026
Same journal

Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

Current pharmaceutical design·2026
Same journal

Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

Current pharmaceutical design·2026
Same journal

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical design·2026
Same journal

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

Current pharmaceutical design·2026
Same journal

Corrigendum to: miRNA in Diagnosis and Therapeutics of Tuberculosis: Importance in Latent and Brain Associated Pathologies.

Current pharmaceutical design·2026
See all related articles

Highly active antiretroviral therapy significantly reduces HIV morbidity and mortality. Guidelines offer comprehensive strategies for treatment, prophylaxis, and special populations, ensuring durable viral suppression and immune reconstitution.

Area of Science:

  • Infectious Diseases
  • Virology
  • Immunology

Background:

  • Highly active antiretroviral therapy (HAART) has dramatically decreased HIV-related illness and death.
  • Current HIV treatments target viral entry, transcription, and maturation.
  • Combination therapy is crucial for sustained viral suppression and immune recovery.

Purpose of the Study:

  • To summarize current U.S. and international guidelines for HIV treatment and management.
  • To highlight considerations for antiretroviral therapy in special populations.
  • To review HIV pathophysiology, viral load testing, dynamics, and antiretroviral classification.

Main Methods:

  • Review of U.S. Department of Health and Human Services Guidelines for Antiretroviral Agents.
  • Summary of International AIDS Society-USA Panel recommendations.

Related Experiment Videos

  • Inclusion of U.S. Public Health Service and WHO guidelines for specific scenarios.

    • Main Results:

    • Guidelines provide comprehensive approaches to HIV management, including prophylaxis.
    • Special populations (e.g., pregnancy, co-infections) require tailored antiretroviral therapy selection.
    • Recommendations cover occupational exposure, postexposure prophylaxis, and resource-limited settings.

    Conclusions:

    • Adherence to established guidelines ensures effective HIV treatment and improved patient outcomes.
    • Management of HIV requires a multifaceted approach considering viral dynamics and individual patient factors.
    • Ongoing research and guideline updates are essential for optimizing HIV care globally.